Search

everythinglearnresearchcommunity

for

Search:↓

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Moxibustion may help improve ovarian function by changing androgen levels.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Certain gene variations are not a major cause of male infertility in Nigerian men.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.